Bayer, Janssen Win Another Xarelto Injury Trial In Philly

Posted on Posted in Xarelto

Law360 (August 30, 2018, 7:01 PM EDT) — Bayer AG and Janssen Pharmaceuticals Inc. notched the latest in a string of victories in litigation over injuries allegedly linked to the anticoagulant medication Xarelto on Thursday as a Philadelphia jury rejected claims that the companies failed to provide adequate warnings about the drug’s risks. Bayer and […]

Warning About the Risks of Combining Aspirin with Xarelto

Posted on Posted in Xarelto

As parties prepare for the second Xarelto bellwether trial in the Xarelto Multidistrict Litigation (MDL)in the Eastern District of Louisiana, the Institute of Safe Medication Practices (ISMP) has released their QuarterWatch report for the third quarter of 2016. Among the institute’s findings is an increase in aspirin-related bleeding events, which they believe is actually related […]

Scovern Law Reports Over 18,000 Xarelto Cases Filed as Second Bellwether Trial Set to Get Underway

Posted on Posted in Xarelto

SAN FRANCISCO, May 24, 2017 — Xarelto patients who suffered internal bleeding and other life-threatening complications allegedly related to use of the medication continue to file lawsuits in courts throughout the U.S. According to a May 3rd filing with the U.S. Securities and Exchange Commission, Johnson & Johnson and Bayer AG have been named defendants […]

Bayer, Janssen Score Win In 1st Xarelto Trial

Posted on Posted in Xarelto

(May 4, 2017) – A Louisiana federal jury on Wednesday sided with Janssen and Bayer in the first bellwether trial in multidistrict litigation over unstoppable bleeding allegedly caused by their blood thinner Xarelto. The jury found in favor of Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. in the first of […]

Janssen, Bayer Lose Preemption Bids As Xarelto Trial Nears

Posted on Posted in Xarelto

Law360, New York (April 13, 2017, 8:52 PM EDT) — Days before a first bellwether trial begins in multidistrict litigation over the alleged dangers of blood thinner Xarelto, a Louisiana federal judge on Wednesday refused to drop some claims against Bayer AG and Janssen Pharmaceuticals Inc., saying they can’t necessarily blame U.S. Food and Drug […]

More Than 13,000 Xarelto Lawsuits Filed

Posted on Posted in Xarelto

The number of Xarelto lawsuits surpasses over 13,000 pending cases in courts around the nation. The lawsuits target Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. The suits claim that the company, along with Bayer AG, failed to provide consumers with adequate warnings about the potentially dangerous side effects of taking the medication. The lawsuits […]

Four XARELTO Trials Scheduled for 2017

Posted on Posted in Xarelto

SAN FRANCISCO, CALIF., UNITED STATES, February 25, 2017 — Plaintiffs in the four lawsuits picked to be tried first in the Xarelto multi-district litigation (MDL) will have to wait a little longer to see their day in court. The four bellwether trials were pushed back another month at the behest of both plaintiffs and defendants. […]

Questions raised about clinical trial of heart drugs rivaroxaban (Xarelto) and warfarin – CBS News

Posted on Posted in Xarelto

New questions are being raised about the clinical trial of a widely used heart drug, and critics are calling for an independent investigation, after a medical device used during the study was later found to be faulty and recalled. The clinical trial tested a blood-thinning medication called rivaroxaban, which is now marketed under the brand […]